play_arrow
Jamz 103.3
Battling to regain its market share over rival Eli Lilly, Novo Nordisk announced Tuesday that it will reduce the list prices of its popular weight loss drug Wegovy and diabetes drugs Ozempic and Rybelsus by up to half starting in 2027. Read More
Written by: admin
Copyright©2025 Sky Media Inc
Post comments (0)